Colin Hill to Speak at PMWC23
The Precision Medicine World Conference – PMWC is the largest annual conference dedicated to precision medicine. PMWC’s mission is to bring together recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors, there by catalyzing cross-functional fertilization […]
Meet us at J.P. Morgan
Join us at our first conference of the new year at J.P. Morgan in San Francisco, January 9-12, 2023. We’ll be there to talk about how Aitia is revealing the hidden biological mechanisms of disease to create Digital Twins of disease in oncology, neurodegenerative disorders, and immunology. Let’s connect and talk more about Aitia’s focus […]
The Milken Institute Future of Health Summit – “Is AI Just What the Doctor-or Patient-Ordered?” Panel Discussion
The Milken Institute Future of Health Summit (FHS) convened the best minds in the world to confront the most significant health challenges by matching human, financial, and scientific resources with the most innovative, inclusive, and impactful ideas. Watch now the Future of Health Summit and the panel titled “Is AI Just What the Doctor-or Patient-Ordered?” […]
GNS Announces Oral Poster Presentation and Abstract at ASH
The 64th ASH Annual Meeting and Exposition is scheduled to take place December 10-13, 2022 in New Orleans, Louisiana. GNS today announced an oral poster presentation and an abstract highlighting insight from the Gemini Digital Twin model in Multiple Myeloma. Oral and Poster Abstracts: Monday, December 12, 2022: 6:00 PM-8:00 PM Abstract Number 4804: Causal AI in silico Patient […]
GNS Announces Oral Poster Presentation and Abstract at CTAD
The 15th annual Clinical Trials on Alzheimer’s Disease (CTAD) will be held in San Francisco on November 29 – December 2, 2022. GNS today announced an oral poster presentation and an abstract highlighting insight from the Gemini Digital Twin model in Alzheimer Disease. Oral Poster Presentation: Friday, December 2nd from 8am to 5pm PT. Abstract […]
Intelligent Technology Brings Companies To A New Moment Of Truth
“Algorithms have long been used to uncover correlations but now they are closing in on more human-like abilities such as common sense and the understanding of causation.” Paul R. Daugherty and H. James Wilson, discuss in this article the future of AI and refer to it as A New Moment of Truth. GNS causal AI […]
GNS Attending BioTechX Europe’s Largest Congress
BioTechX is Europe’s largest congress covering latest breakthroughs in pharmaceutical development and healthcare. This year, GNS is attending this world-class congress, and our own Colin Hill will be speaking on Nov 8 at 14:50 (CET) on the Recent Application of Digital Twins in Drug Discovery and Development for Alzheimer’s Disease. Make sure to bookmark your […]
Bruce Church to Speak at the Human Vaccines Project
Over 20 years ago, the sequencing of the human genome revolutionized biomedical research and ushered in a new era of precision medicine. On September 27-29, 2022, The Human Vaccines Project will convene a summit to map out the next frontier in human biology: How to Build an AI Model of the Human Immunome. The primary […]
Colin Hill to Give Keynote at the 26th Annual Merck Technology Symposium
The Merck Technology Symposium is an annual event that brings together upwards of 2,000 scientists and over 70 external vendors to hear about innovations in new therapeutic approaches, applications of new technology, and accelerating the pace at which we deliver medicines to patients. The meeting will be organized around several tracks illustrating the various ways […]
Colin Hill moderating Fireside Chat at Longwood Healthcare Leaders Fall meeting
Once again, GNS is a proud supporter of Longwood Healthcare Leaders. This Fall webconference brings together leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors for an off-the-record forum focused on accelerating the translation of discoveries into medicines to help patients. On Thursday, September 22, 2022, our CEO Colin Hill will be […]